← brief for 2026-10-08 · Slowing decline

Functional, Hemodynamic and Molecular Determinants for Evaluating the Efficacy of Sodium-glucose Cotransporter-2 Inhibitor Therapy in Diabetic Kidney Disease.

Article No results yet Peer reviewed

Key takeaways

This review explains how doctors can measure the effects of SGLT2 drugs. These drugs help people with diabetic kidney disease. The review looks at blood flow and body chemistry to track how well the drugs work.

Who did this work

Mathew GG

Source

Article · PubMed, the drug frontier · 2026 Oct 7
https://pubmed.ncbi.nlm.nih.gov/42844933/